HIGHLIGHTS
- who: Nafiseh Ghazanfari and collaborators from the University of have published the Article: Binding of the Dual-Action Anti-Parkinsonian Drug AG-0029 to Dopamine D2 and Histamine H3 Receptors: A PET Study in Healthy Rats, in the Journal: (JOURNAL) of July/13,/2022
- what: Https://doi.org/10.1021/acs.molpharmaceut.2c00121 Mol.
SUMMARY
Pharmaceutics 2022, 19, 2287-2298 pubs.acs.org/molecularpharmaceutics only pathological protein deposition but also changes in neurotransmitter pathways occur years before the onset of clinical manifestations. The balance in the nigrostriatal dopamine pathway, which originates . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.